VERTEX PHARMACEUTICALS INC / MA Accrued Liabilities 2009-2026 | VRTX
What is accrued liabilities?
Accrued liabilities are expenses that have been incurred but not yet paid, such as wages, interest, and taxes payable.
What is VERTEX PHARMACEUTICALS INC / MA's current accrued liabilities?
VERTEX PHARMACEUTICALS INC / MA (VRTX) annual accrued liabilities for 2025 was $2.97B, a 6.55% increase from 2024. VERTEX PHARMACEUTICALS INC / MA accrued liabilities for the quarter ending March 31, 2026 was $2.98B.
What was VERTEX PHARMACEUTICALS INC / MA's accrued liabilities in 2024?
VERTEX PHARMACEUTICALS INC / MA annual accrued liabilities for 2024 was $2.79B, a 5.02% increase from 2023.
What was VERTEX PHARMACEUTICALS INC / MA's accrued liabilities in 2023?
VERTEX PHARMACEUTICALS INC / MA annual accrued liabilities for 2023 was $2.66B, a 24.86% increase from 2022.
What is VERTEX PHARMACEUTICALS INC / MA's 5-year accrued liabilities CAGR?
VERTEX PHARMACEUTICALS INC / MA accrued liabilities grew at a compound annual growth rate (CAGR) of 16.16% from FY2020 to FY2025, going from $1.41B to $2.97B over 5 years.
Year-over-year comparison from 10-K annual reports
| Period | Value | Change | Source |
|---|---|---|---|
| FY2025 | $2.97B | +6.5% | 10-K |
| FY2024 | $2.79B | +5.0% | 10-K |
| FY2023 | $2.66B | +24.9% | 10-K |
| FY2022 | $2.13B | +26.7% | 10-K |
| FY2021 | $1.68B | +19.5% | 10-K |
| FY2020 | $1.41B | +25.8% | 10-K |
| FY2019 | $1.12B | +16.5% | 10-K |
| FY2018 | $958.9M | +116.0% | 10-K |
| FY2017 | $444.0M | +40.8% | 10-K |
| FY2016 | $315.2M | +3.1% | 10-K |
| FY2015 | $305.8M | +45.9% | 10-K |
| FY2014 | $209.7M | -22.7% | 10-K |
| FY2013 | $271.1M | +2.3% | 10-K |
| FY2012 | $264.9M | +8.9% | 10-K |
| FY2011 | $243.2M | +80.9% | 10-K |
| FY2010 | $134.4M | +13.2% | 10-K |
| FY2009 | $118.8M | - | 10-K |